Our proposal responds to the NIH program announcement """"""""Development of assays for high throughput drug screening,"""""""" which has the goal of offering public sector researchers opportunities to employ high throughput chemical screening (HTS) methods. The announcement asks applicants to propose development plans sufficient to show assay reproducibility; to test the assay with a small compound library; and to provide an outline for evaluating the significance of HTS hits. We describe a unique assay designed to identify compounds that inhibit HIV assembly. Our cell-based assay takes advantage of the fact that chimeric proteins can serve as sensitive, efficient, and reproducible reporters for virus assembly with signal-to-noise ratios that should be suitable for HTS. Our investigations will lead to the identification of compounds that inhibit transport, assembly and release of virions from virus-expressing cells. Such inhibitors will provide new HIV antivirals, will help unravel the complicated choreography of HIV assembly, and may reveal ways to block the replication of other pathogenic viruses. Thus, the results of our studies will have general applicability in understanding the HIV life cycle and in stopping virus infections. In keeping with program announcement guidelines, to achieve these goals, our specific aims are as follows: 1. Optimization of assembly assays for high throughput screening: Assembly assays will be modified to reduce assay-to-assay variability, improve signal-to-noise ratios, increase screening coefficient ratios, and adapt protocols for HTS formats. 2. Assay characterization using small chemical libraries: Optimized screening protocols will be employed to test small chemical libraries of diverse compound sets. Test screen data will be evaluated to assess statistical screening parameters, and results will be used to further refine methodologies for HTS. 3. Development of secondary screening procedures: Procedures for analysis and prioritization of primary hits will be developed and streamlined. Methods to rule out artifacts, and to discriminate specific assembly steps impacted by candidate inhibitors will be designed and tested. Through these efforts, the prospect of finding novel HIV inhibitors, and elucidating new assembly steps will be realized. ? Public Health Relevance: Our investigations are directly relevant to public health. We propose to develop a high throughput screen that will identify inhibitors of HIV assembly. Such inhibitors will serve as leads in the design of novel drugs for the treatment of AIDS. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI071798-01A2
Application #
7338917
Study Section
AIDS Discovery and Development of Therapeutics Study Section (ADDT)
Program Officer
Black, Paul L
Project Start
2007-07-01
Project End
2011-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$385,000
Indirect Cost
Name
Oregon Health and Science University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Alfadhli, Ayna; McNett, Henry; Eccles, Jacob et al. (2013) Analysis of small molecule ligands targeting the HIV-1 matrix protein-RNA binding site. J Biol Chem 288:666-76
Noviello, Colleen M; Lopez, Claudia S; Kukull, Ben et al. (2011) Second-site compensatory mutations of HIV-1 capsid mutations. J Virol 85:4730-8
Alfadhli, Ayna; McNett, Henry; Tsagli, Seyram et al. (2011) HIV-1 matrix protein binding to RNA. J Mol Biol 410:653-66
Lopez, Claudia S; Eccles, Jacob D; Still, Amelia et al. (2011) Determinants of the HIV-1 core assembly pathway. Virology 417:137-46
Still, Amelia; Huseby, Douglas; Barklis, Eric (2011) Analysis of the N-terminal region of the murine leukemia virus nucleocapsid protein. Virus Res 155:181-8
Dikeakos, Jimmy D; Atkins, Katelyn M; Thomas, Laurel et al. (2010) Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol Biol Cell 21:3279-92
Barklis, Eric; Alfadhli, Ayna; McQuaw, Carolyn et al. (2009) Characterization of the in vitro HIV-1 capsid assembly pathway. J Mol Biol 387:376-89
Alfadhli, Ayna; Still, Amelia; Barklis, Eric (2009) Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids. J Virol 83:12196-203
Alfadhli, Ayna; Barklis, Robin Lid; Barklis, Eric (2009) HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology 387:466-72
Scholz, Isabel; Still, Amelia; Dhenub, Tenzin Choesang et al. (2008) Analysis of human immunodeficiency virus matrix domain replacements. Virology 371:322-35